Authors :
Costin Leu, PhD – Cleveland Clinic; Javier López-Rivera, PhD – Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, US; Marie Macnee, PhD – Cologne Center for Genomics (CCG), University of Cologne, Faculty of Medicine and University Hospital Cologne, 50931 Cologne, Germany; Jean Khoury, MD – Charles Shor Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, US; Lucas Hoffmann, MD – Department of Neuropathology, University Hospital Erlangen, Erlangen, Germany; Roland Coras, MD – Department of Neuropathology, University Hospital Erlangen, Erlangen, Germany; Katja Kobow, PhD – Department of Neuropathology, University Hospital Erlangen, Erlangen, Germany; Nisha Bhattarai, PhD – Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, US; Eduardo Pérez-Palma, PhD – Universidad del Desarrollo, Centro de Genética y Genómica, Facultad de Medicina Clínica Alemana. Santiago 7610658, Chile; Hajo Hamer, MD – Epilepsy Center, University Hospital Erlangen, Erlangen, Germany; Sebastian Brandner, MD – Department of Neurosurgery, University Hospital Erlangen, Erlangen, Germany; Karl Rössler, MD – Department of Neurosurgery, Medical University Vienna, Vienna, Austria; Christian Bien, MD – Department of Epileptology (Krankenhaus Mara), Medical School, Bielefeld University, Bielefeld, Germany; Thilo Kalbhenn, MD – Department of Neurosurgery - Epilepsy surgery, Evangelisches Klinikum Bethel, Universitätsklinikum OWL, Bielefeld University, Bielefeld, Germany; Tom Pieper, MS – Center for Pediatric Neurology, Neurorehabilitation, and Epileptology, Schoen-Clinic, Vogtareuth, Germany; Till Hartlieb, MD – Center for Pediatric Neurology, Neurorehabilitation, and Epileptology, Schoen-Clinic, Vogtareuth, Germany; Elizabeth Butler, PA – Charles Shor Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, US; Giulio Genovese, PhD – Stanley Center for Psychiatric Research, Broad Institute of Harvard and M.I.T, Cambridge, MA 02142, US; Kerstin Becker, PhD – Cologne Center for Genomics (CCG), University of Cologne, Faculty of Medicine and University Hospital Cologne, 50931 Cologne, Germany; Janine Altmüller, PhD – Cologne Center for Genomics (CCG), University of Cologne, Faculty of Medicine and University Hospital Cologne, 50931 Cologne, Germany; Lisa-Marie Niestroj, PhD – Cologne Center for Genomics (CCG), University of Cologne, Faculty of Medicine and University Hospital Cologne, 50931 Cologne, Germany; Lisa Ferguson, MA – Charles Shor Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, US; Robyn Busch, PhD – Charles Shor Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, US; Peter Nürnberg, PhD – Cologne Center for Genomics (CCG), University of Cologne, Faculty of Medicine and University Hospital Cologne, 50931 Cologne, Germany; Imad Najm, MD – Charles Shor Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, US; Ingmar Blümcke, PhD – Department of Neuropathology, University Hospital Erlangen, Erlangen, Germany; Dennis Lal, PhD – Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, US